A carregar...

A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer

Breast cancer remains a leading cause of disease and death among women throughout the world. Despite advances in drug therapy, development of novel and improved drugs for breast cancer continues to be of great interest. Lapatinib is a novel dual receptor tyrosine kinase inhibitor that is a selective...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nelson, Michael H, Dolder, Christian R
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374939/
https://ncbi.nlm.nih.gov/pubmed/18472989
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!